Financial reports
ARS
2023 FY
Annual report to shareholders
26 Apr 24
10-K
2023 FY
Annual report
27 Feb 24
10-Q
2023 Q3
Quarterly report
2 Nov 23
10-Q
2023 Q2
Quarterly report
3 Aug 23
10-Q
2023 Q1
Quarterly report
4 May 23
ARS
2022 FY
Annual report to shareholders
27 Apr 23
10-K
2022 FY
Annual report
28 Feb 23
10-Q
2022 Q3
Quarterly report
3 Nov 22
10-Q
2022 Q2
Quarterly report
4 Aug 22
10-Q
2022 Q1
Quarterly report
5 May 22
Current reports
8-K
Alignment Healthcare Reports Fourth Quarter and Full-Year 2023 Results; Provides Full-Year 2024 Financial Guidance
27 Feb 24
8-K
Regulation FD Disclosure
8 Jan 24
8-K
Departure of Directors or Certain Officers
29 Dec 23
8-K
Alignment Healthcare Reports Third Quarter 2023 Results; Exceeds Guidance Across All Key Financial Metrics
2 Nov 23
8-K
Departure of Directors or Certain Officers
15 Sep 23
8-K
Departure of Directors or Certain Officers
6 Sep 23
8-K
Departure of Directors or Certain Officers
15 Aug 23
8-K
Alignment Healthcare Reports Second Quarter 2023 Results; Beats Outlook Across All Four Critical KPIs
3 Aug 23
8-K
Departure of Directors or Certain Officers
14 Jul 23
8-K
Submission of Matters to a Vote of Security Holders
9 Jun 23
Registration and prospectus
424B7
Prospectus with selling stockholder info
19 Sep 22
424B7
Prospectus with selling stockholder info
15 Sep 22
S-3ASR
Automatic shelf registration
15 Sep 22
424B4
Prospectus supplement with pricing info
19 Nov 21
S-1
IPO registration
16 Nov 21
DRS
Draft registration statement
1 Jul 21
S-8
Registration of securities for employees
30 Mar 21
424B4
Prospectus supplement with pricing info
29 Mar 21
8-A12B
Registration of securities on exchange
26 Mar 21
S-1/A
IPO registration (amended)
23 Mar 21
Proxies
DEFA14A
Additional proxy soliciting materials
26 Apr 24
DEF 14A
Definitive proxy
26 Apr 24
PRE 14A
Preliminary proxy
12 Apr 24
DEFA14A
Additional proxy soliciting materials
26 Apr 23
DEF 14A
Definitive proxy
26 Apr 23
DEFA14A
Additional proxy soliciting materials
28 Apr 22
DEF 14A
Definitive proxy
28 Apr 22
Other
EFFECT
Notice of effectiveness
19 Nov 21
CORRESP
Correspondence with SEC
16 Nov 21
CORRESP
Correspondence with SEC
16 Nov 21
UPLOAD
Letter from SEC
7 Jul 21
CERT
Certification of approval for exchange listing
26 Mar 21
EFFECT
Notice of effectiveness
26 Mar 21
CORRESP
Correspondence with SEC
23 Mar 21
CORRESP
Correspondence with SEC
23 Mar 21
CORRESP
Correspondence with SEC
23 Mar 21
UPLOAD
Letter from SEC
22 Mar 21
Ownership
4
Robert L. Scavo
29 Mar 24
4
Dawn Christine Maroney
29 Mar 24
4
Robert Thomas Freeman
29 Mar 24
4
Hakan Kardes
29 Mar 24
144
Notice of proposed sale of securities
28 Mar 24
144
Notice of proposed sale of securities
28 Mar 24
144
Notice of proposed sale of securities
28 Mar 24
144
Notice of proposed sale of securities
28 Mar 24
4
Dawn Christine Maroney
21 Mar 24
4
Robert L. Scavo
21 Mar 24